Develops proprietary gene delivery systems and provides development expertise to create gene-based therapeutics designed for the treatment or prevention of genetic and acquired diseases. TheCompany has developed several in vivo, non-viral gene delivery systems to address a number of potential therapeutic applications using trial agreement with the University of Colorado to develop a gene-based immunotherapeutic for cancer.
Develops proprietary gene delivery systems and provides development expertise to create gene-based therapeutics designed for the treatment or prevention of genetic and acquired diseases. TheCompany has developed several in vivo, non-viral gene delivery systems to address a number of potential therapeutic applications using trial agreement with the University of Colorado to develop a gene-based immunotherapeutic for cancer.